Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Lymphoma

Free Subscription Articles published in Radiother Oncol Retrieve available abstracts of 13 articles: HTML format

Single Articles

September 2023
1. WANG X, Liu X, Zhong QZ, Wu T, et al
   Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.
   Radiother Oncol. 2023 Sep 5:109902. doi: 10.1016/j.radonc.2023.109902.
   PubMed     Abstract available
   
   
   August 2023
2. HOFFMANN L, Ehmsen ML, Hansen J, Hansen R, et al
   Repeated deep-inspiration breath-hold CT scans at planning underestimate the actual motion between breath-holds at treatment for lung cancer and lymphoma patients.
   Radiother Oncol. 2023 Aug 31:109887. doi: 10.1016/j.radonc.2023.109887.
   PubMed     Abstract available
   
   
   June 2023
3. FAN J, Adams A, Sieg N, Heger JM, et al
   Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy.
   Radiother Oncol. 2023;183:109580.
   PubMed     Abstract available
   
   
   March 2023
4. CANTERS R, Vaassen F, Lubken I, Cobben M, et al
   Radiotherapy for mediastinal lymphoma in breath hold using surface monitoring and nasal high flow oxygen: clinical experiences and breath hold stability.
   Radiother Oncol. 2023 Mar 2:109594. doi: 10.1016/j.radonc.2023.109594.
   PubMed     Abstract available
   
   
   October 2022
5. YU Q, Zhang X, Wang N, Li C, et al
   Radiation prior to Chimeric Antigen Receptor T-cell Therapy is an Optimizing Bridging Strategy in Relapse/Refractory Aggressive B-cell Lymphoma.
   Radiother Oncol. 2022 Oct 26. pii: S0167-8140(22)04513.
   PubMed     Abstract available
   
   
   
6. PATEL CG, Peterson J, Aznar M, Tseng YD, et al
   Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations.
   Radiother Oncol. 2022 Oct 14. pii: S0167-8140(22)04497.
   PubMed     Abstract available
   
   
   
7. ABABNEH HS, Abramson JS, Johnson PC, Patel CG, et al
   Assessing the role of radiotherapy in patients with refractory or relapsed high-grade B-cell lymphomas treated with CAR T-cell therapy.
   Radiother Oncol. 2022;175:65-72.
   PubMed     Abstract available
   
   
   August 2022
8. WU Y, Liu X, Imber BS, Zhong QZ, et al
   Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015).
   Radiother Oncol. 2022;173:179-187.
   PubMed     Abstract available
   
   
   April 2022
9. RIGHETTO R, Fracchiolla F, Widesott L, Lorentini S, et al
   Technical challenges in the treatment of mediastinal lymphomas by proton pencil beam scanning and deep inspiration breath-hold.
   Radiother Oncol. 2022;169:43-50.
   PubMed     Abstract available
   
   
   February 2022
10. XIANG M, Raldow AC, Pollom EL, Steinberg ML, et al
    Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types.
    Radiother Oncol. 2022;167:308-316.
    PubMed     Abstract available
    
    
    January 2022
11. TRINGALE KR, Modlin LA, Sine K, Forlenza CJ, et al
    Vital organ sparing with proton therapy for pediatric hodgkin lymphoma: Toxicity and outcomes in 50 patients.
    Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00020.
    PubMed     Abstract available
    
    
    
12. GAIDE O, Herrera F, Sozzi WJ, Goncalves Jorge P, et al
    Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma.
    Radiother Oncol. 2022 Jan 5. pii: S0167-8140(21)09093.
    PubMed     Abstract available
    
    
    December 2021
13. SAIFI O, Breen WG, Lester SC, Rule WG, et al
    Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?
    Radiother Oncol. 2021;166:171-179.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.